Boltwood Capital Management Abbott Laboratories Transaction History

Boltwood Capital Management

$336 Million
Q3 2024

A detailed history of Boltwood Capital Management transactions in Abbott Laboratories stock. As of the latest transaction made, Boltwood Capital Management holds 21,821 shares of ABT stock, worth $2.59 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

21,821

Previous 21,732 0.41%

Holding current value

$2.59 Million

Previous $2.26 Million 10.14%

% of portfolio

0.74%

Previous 0.71%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 02, 2024	BUY	$100.07 - $118.13 $8,906 - $10,513	89 Added 0.41%	21,821 $2.49 Million
Q2 2024 Jul 08, 2024	SELL	$100.73 - $112.44 $33,744 - $37,667	-335 Reduced 1.52%	21,732 $2.26 Million
Q1 2024 Apr 04, 2024	SELL	$109.52 - $120.96 $63,850 - $70,519	-583 Reduced 2.57%	22,067 $2.51 Million
Q4 2023 Jan 05, 2024	SELL	$90.19 - $110.4 $14,881 - $18,216	-165 Reduced 0.72%	22,650 $2.49 Million
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $40,791 - $48,942	-427 Reduced 1.84%	22,815 $2.21 Million
Q2 2023 Jul 06, 2023	SELL	$100.78 - $112.29 $17,636 - $19,650	-175 Reduced 0.75%	23,242 $2.53 Million
Q1 2023 Apr 03, 2023	SELL	$96.86 - $114.01 $1,065 - $1,254	-11 Reduced 0.05%	23,417 $2.37 Million
Q4 2022 Jan 06, 2023	SELL	$95.06 - $111.52 $65,401 - $76,725	-688 Reduced 2.85%	23,428 $0
Q3 2022 Oct 04, 2022	BUY	$96.76 - $112.03 $8,321 - $9,634	86 Added 0.36%	24,116 $2.33 Million
Q2 2022 Jul 07, 2022	SELL	$102.07 - $123.37 $22,353 - $27,018	-219 Reduced 0.9%	24,030 $2.61 Million
Q1 2022 Apr 20, 2022	SELL	$114.02 - $139.04 $31,013 - $37,818	-272 Reduced 1.11%	24,249 $2.87 Million
Q4 2021 Jan 10, 2022	SELL	$115.53 - $141.46 $7,509 - $9,194	-65 Reduced 0.26%	24,521 $3.45 Million
Q3 2021 Oct 08, 2021	SELL	$116.66 - $129.06 $15,632 - $17,294	-134 Reduced 0.54%	24,586 $2.9 Million
Q2 2021 Jul 06, 2021	BUY	$105.79 - $124.53 $8,992 - $10,585	85 Added 0.35%	24,720 $2.87 Million
Q1 2021 Apr 05, 2021	SELL	$108.84 - $128.23 $174,252 - $205,296	-1,601 Reduced 6.1%	24,635 $2.95 Million
Q4 2020 Jan 04, 2021	SELL	$105.0 - $114.42 $28,980 - $31,579	-276 Reduced 1.04%	26,236 $2.87 Million
Q3 2020 Oct 05, 2020	SELL	$91.64 - $111.29 $7,789 - $9,459	-85 Reduced 0.32%	26,512 $2.89 Million
Q2 2020 Jul 02, 2020	SELL	$76.57 - $98.0 $37,366 - $47,824	-488 Reduced 1.8%	26,597 $2.43 Million
Q1 2020 Apr 07, 2020	SELL	$62.82 - $91.86 $62,882 - $91,951	-1,001 Reduced 3.56%	27,085 $2.14 Million
Q4 2019 Jan 07, 2020	BUY	$78.51 - $87.4 $23,317 - $25,957	297 Added 1.07%	28,086 $2.44 Million
Q3 2019 Oct 02, 2019	BUY	$81.84 - $88.74 $10,639 - $11,536	130 Added 0.47%	27,789 $2.33 Million
Q2 2019 Jul 01, 2019	SELL	$72.88 - $85.0 $7,725 - $9,010	-106 Reduced 0.38%	27,659 $2.33 Million
Q1 2019 Apr 02, 2019	BUY	$66.22 - $80.06 $3,708 - $4,483	56 Added 0.2%	27,765 $2.22 Million
Q4 2018 Jan 07, 2019	SELL	$65.56 - $74.27 $13,112 - $14,854	-200 Reduced 0.72%	27,709 $2 Million
Q3 2018 Oct 10, 2018	BUY	$60.81 - $73.36 $14,229 - $17,166	234 Added 0.85%	27,909 $2.05 Million
Q2 2018 Jul 06, 2018	BUY	$57.57 - $63.54 $160,505 - $177,149	2,788 Added 11.2%	27,675 $1.69 Million
Q1 2018 Apr 05, 2018	SELL	$56.27 - $63.62 $82,323 - $93,076	-1,463 Reduced 5.55%	24,887 $1.49 Million
Q4 2017 Jan 10, 2018	BUY	$53.68 - $57.47 $19,271 - $20,631	359 Added 1.38%	26,350 $1.5 Million
Q3 2017 Oct 10, 2017	BUY	$48.06 - $53.64 $1.25 Million - $1.39 Million	25,991	25,991 $1.39 Million

Others Institutions Holding ABT

# of Institutions

3,167

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boltwood Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Boltwood Capital Management with notifications on news.

Account

Boltwood Capital Management Abbott Laboratories Transaction History